GUVVALI, DHARMENDER, and DIBYALOCHAN MOHANTY. 2026. “A QUALITY BY DESIGN DRIVEN DEVELOPMENT AND CHARACTERIZATION OF PALBOCICLIB-LOADED MESOPOROUS SILICA NANOPARTICLES IN HEPATOCELLULAR CARCINOMA THERAPY: ASSESSMENT OF CYTOTOXIC AND APOPTOTIC EFFECTS ON HEPG2 CELL LINE”. International Journal of Applied Pharmaceutics 18 (3). https://doi.org/10.22159/ijap.2026v18i3.57785.